KRT73
gene geneOn this page
Also known as KRT6IRS3K6IRS3
Summary
KRT73 (keratin 73, HGNC:28928) is a protein-coding gene on chromosome 12q13.13, encoding Keratin, type II cytoskeletal 73 (Q86Y46). Has a role in hair formation.
Keratins are intermediate filament proteins responsible for the structural integrity of epithelial cells and are subdivided into epithelial keratins and hair keratins. This gene encodes a protein that is expressed in the inner root sheath of hair follicles. The type II keratins are clustered in a region of chromosome 12q13.
Source: NCBI Gene 319101 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 111 total
- MANE Select transcript:
NM_175068
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28928 |
| Approved symbol | KRT73 |
| Name | keratin 73 |
| Location | 12q13.13 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KRT6IRS3, K6IRS3 |
| Ensembl gene | ENSG00000186049 |
| Ensembl biotype | protein_coding |
| OMIM | 608247 |
| Entrez | 319101 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 2 protein_coding, 1 retained_intron
ENST00000305748, ENST00000546934, ENST00000552855
RefSeq mRNA: 1 — MANE Select: NM_175068
NM_175068
CCDS: CCDS8834
Canonical transcript exons
ENST00000305748 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001270376 | 52607570 | 52608452 |
| ENSE00001270422 | 52618078 | 52618559 |
| ENSE00001720813 | 52610615 | 52610835 |
| ENSE00001777807 | 52611204 | 52611329 |
| ENSE00003539659 | 52615279 | 52615339 |
| ENSE00003569369 | 52616166 | 52616380 |
| ENSE00003586796 | 52613688 | 52613852 |
| ENSE00003630974 | 52609247 | 52609281 |
| ENSE00003650163 | 52614579 | 52614674 |
Expression profiles
Bgee: expression breadth broad, 73 present calls, max score 84.10.
Top tissues by expression
227 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| skin of leg | UBERON:0001511 | 84.10 | gold quality |
| zone of skin | UBERON:0000014 | 80.78 | gold quality |
| skin of abdomen | UBERON:0001416 | 80.69 | gold quality |
| granulocyte | CL:0000094 | 79.44 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 76.93 | silver quality |
| sperm | CL:0000019 | 68.74 | gold quality |
| blood | UBERON:0000178 | 63.41 | gold quality |
| lymph node | UBERON:0000029 | 58.27 | gold quality |
| skin of hip | UBERON:0001554 | 57.63 | silver quality |
| vermiform appendix | UBERON:0001154 | 56.41 | gold quality |
| jejunal mucosa | UBERON:0000399 | 54.52 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 54.34 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 54.23 | gold quality |
| kidney epithelium | UBERON:0004819 | 53.93 | gold quality |
| caecum | UBERON:0001153 | 53.92 | gold quality |
| endothelial cell | CL:0000115 | 53.81 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 53.46 | gold quality |
| duodenum | UBERON:0002114 | 53.24 | gold quality |
| amniotic fluid | UBERON:0000173 | 52.89 | gold quality |
| cartilage tissue | UBERON:0002418 | 52.67 | gold quality |
| gingival epithelium | UBERON:0001949 | 52.54 | gold quality |
| nipple | UBERON:0002030 | 52.11 | gold quality |
| spleen | UBERON:0002106 | 51.83 | gold quality |
| quadriceps femoris | UBERON:0001377 | 50.92 | gold quality |
| bone marrow | UBERON:0002371 | 50.91 | gold quality |
| oocyte | CL:0000023 | 50.84 | gold quality |
| vastus lateralis | UBERON:0001379 | 50.59 | gold quality |
| myocardium | UBERON:0002349 | 50.25 | gold quality |
| pancreatic ductal cell | CL:0002079 | 50.15 | silver quality |
| bone marrow cell | CL:0002092 | 50.00 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.27 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): SHH
miRNA regulators (miRDB)
42 targeting KRT73, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4692 | 100.00 | 67.32 | 2066 |
| HSA-MIR-432-3P | 100.00 | 67.86 | 705 |
| HSA-MIR-4514 | 99.99 | 67.10 | 1870 |
| HSA-MIR-4267 | 99.96 | 66.53 | 2368 |
| HSA-MIR-6825-5P | 99.96 | 69.81 | 3431 |
| HSA-MIR-381-3P | 99.93 | 71.87 | 2854 |
| HSA-MIR-300 | 99.92 | 71.76 | 2856 |
| HSA-MIR-380-3P | 99.89 | 70.18 | 1978 |
| HSA-MIR-4428 | 99.73 | 66.41 | 1733 |
| HSA-MIR-4524A-3P | 99.72 | 66.85 | 2406 |
| HSA-MIR-5004-5P | 99.68 | 66.63 | 1294 |
| HSA-MIR-1827 | 99.63 | 68.57 | 3265 |
| HSA-MIR-4516 | 99.61 | 67.78 | 3390 |
| HSA-MIR-1260A | 99.61 | 66.67 | 1098 |
| HSA-MIR-1260B | 99.61 | 66.67 | 1098 |
| HSA-MIR-4441 | 99.49 | 66.56 | 3216 |
| HSA-MIR-1224-5P | 99.48 | 65.59 | 803 |
| HSA-MIR-3612 | 99.45 | 66.02 | 1333 |
| HSA-MIR-650 | 99.45 | 65.77 | 1309 |
| HSA-MIR-330-3P | 99.41 | 69.95 | 2521 |
| HSA-MIR-4434 | 99.10 | 67.01 | 1984 |
| HSA-MIR-5703 | 99.10 | 67.09 | 2053 |
| HSA-MIR-485-5P | 99.10 | 64.78 | 1889 |
| HSA-MIR-6884-5P | 99.10 | 64.50 | 1987 |
| HSA-MIR-4650-3P | 99.01 | 68.39 | 1062 |
| HSA-MIR-3926 | 98.95 | 69.26 | 1438 |
| HSA-MIR-936 | 98.87 | 70.51 | 1124 |
| HSA-MIR-222-5P | 98.75 | 69.17 | 1242 |
| HSA-MIR-384 | 98.71 | 67.34 | 1229 |
| HSA-MIR-548S | 98.50 | 67.17 | 1213 |
Literature-anchored findings (GeneRIF, showing 1)
- report on the cloning of two novel human type II keratin cDNAs, K6irs3 and K6irs4, which were specifically expressed in the inner root sheath of the hair follicle (PMID:12648212)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Krt73 | ENSMUSG00000063661 |
| rattus_norvegicus | Krt73 | ENSRNOG00000025087 |
Paralogs (68): KRT33A (ENSG00000006059), VIM (ENSG00000026025), KRT31 (ENSG00000094796), NEFM (ENSG00000104722), KRT23 (ENSG00000108244), KRT37 (ENSG00000108417), KRT32 (ENSG00000108759), KRT18 (ENSG00000111057), LMNB1 (ENSG00000113368), KRT36 (ENSG00000126337), KRT17 (ENSG00000128422), GFAP (ENSG00000131095), KRT34 (ENSG00000131737), KRT33B (ENSG00000131738), NES (ENSG00000132688), PRPH (ENSG00000135406), KRT85 (ENSG00000135443), KRT7 (ENSG00000135480), KRT71 (ENSG00000139648), INA (ENSG00000148798), LMNTD1 (ENSG00000152936), LMNA (ENSG00000160789), KRT84 (ENSG00000161849), KRT82 (ENSG00000161850), KRT80 (ENSG00000167767), KRT1 (ENSG00000167768), KRT24 (ENSG00000167916), KRT8 (ENSG00000170421), KRT78 (ENSG00000170423), KRT86 (ENSG00000170442), KRT75 (ENSG00000170454), KRT6C (ENSG00000170465), KRT4 (ENSG00000170477), KRT74 (ENSG00000170484), KRT72 (ENSG00000170486), KRT83 (ENSG00000170523), BFSP2 (ENSG00000170819), KRT19 (ENSG00000171345), KRT15 (ENSG00000171346), KRT38 (ENSG00000171360)
Protein
Protein identifiers
Keratin, type II cytoskeletal 73 — Q86Y46 (reviewed: Q86Y46)
Alternative names: Cytokeratin-73, Keratin-73, Type II inner root sheath-specific keratin-K6irs3, Type-II keratin Kb36
All UniProt accessions (2): Q86Y46, H0YIC5
UniProt curated annotations — full annotation on UniProt →
Function. Has a role in hair formation. Specific component of keratin intermediate filaments in the inner root sheath (IRS) of the hair follicle.
Subunit / interactions. Heterotetramer of two type I and two type II keratins.
Tissue specificity. Highly expressed in hair follicles from scalp. In hair, it is specifically present in the inner root sheath (IRS) of the hair follicle. Present in the IRS cuticle, but not in Henle or Huxley layers of the IRS. In the IRS cuticle, it is expressed between the lowermost bulb region of the cuticle and the region where Henle cells undergo abrupt terminal differentiation. Detected up to the uppermost cortex region where cuticle cells terminally differentiate (at protein level).
Miscellaneous. There are two types of cytoskeletal and microfibrillar keratin, I (acidic) and II (neutral to basic) (40-55 and 56-70 kDa, respectively).
Similarity. Belongs to the intermediate filament family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q86Y46-1 | 1 | yes |
| Q86Y46-2 | 2 |
RefSeq proteins (1): NP_778238* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR003054 | Keratin_II | Family |
| IPR018039 | IF_conserved | Conserved_site |
| IPR032444 | Keratin_2_head | Domain |
| IPR039008 | IF_rod_dom | Domain |
Pfam: PF00038, PF16208
UniProt features (20 total): region of interest 8, sequence variant 5, splice variant 2, chain 1, domain 1, compositionally biased region 1, site 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q86Y46-F1 | 70.92 | 0.47 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (1): 383 (stutter)
Function
Pathways and Gene Ontology
Reactome pathways
3 pathways
| ID | Pathway |
|---|---|
| R-HSA-6805567 | Keratinization |
| R-HSA-6809371 | Formation of the cornified envelope |
| R-HSA-1266738 | Developmental Biology |
MSigDB gene sets: 79 (showing top):
GSE45365_NK_CELL_VS_CD11B_DC_UP, GOBP_EPITHELIUM_DEVELOPMENT, GOBP_INTERMEDIATE_FILAMENT_BASED_PROCESS, GOBP_INTERMEDIATE_FILAMENT_ORGANIZATION, GOBP_EPIDERMAL_CELL_DIFFERENTIATION, GOBP_EPIDERMIS_DEVELOPMENT, AML1_01, GOBP_KERATINIZATION, GOBP_SKIN_DEVELOPMENT, ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, HOXA4_Q2, ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST, TAATTA_CHX10_01, GOCC_INTERMEDIATE_FILAMENT_CYTOSKELETON, GOCC_KERATIN_FILAMENT
GO Biological Process (2): keratinization (GO:0031424), intermediate filament organization (GO:0045109)
GO Molecular Function (2): structural constituent of skin epidermis (GO:0030280), protein binding (GO:0005515)
GO Cellular Component (5): nucleus (GO:0005634), cytosol (GO:0005829), keratin filament (GO:0045095), extracellular exosome (GO:0070062), intermediate filament (GO:0005882)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Developmental Biology | 1 |
| Keratinization | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| keratinocyte differentiation | 1 |
| multicellular organismal process | 1 |
| intermediate filament cytoskeleton organization | 1 |
| supramolecular fiber organization | 1 |
| structural molecule activity | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
| intermediate filament | 1 |
| extracellular vesicle | 1 |
| intermediate filament cytoskeleton | 1 |
| polymeric cytoskeletal fiber | 1 |
Protein interactions and networks
STRING
424 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KRT73 | KRTAP3-3 | Q9BYR6 | 511 |
| KRT73 | S100A3 | P33764 | 459 |
| KRT73 | CCHCR1 | Q8TD31 | 445 |
| KRT73 | KRTAP16-1 | A8MUX0 | 417 |
| KRT73 | SPINK8 | P0C7L1 | 398 |
| KRT73 | TTC16 | Q8NEE8 | 354 |
| KRT73 | KRTAP3-2 | Q9BYR7 | 353 |
| KRT73 | TMEM74B | Q9NUR3 | 322 |
| KRT73 | USP43 | Q70EL4 | 307 |
| KRT73 | CAMSAP2 | Q08AD1 | 304 |
| KRT73 | CPNE9 | Q8IYJ1 | 297 |
| KRT73 | ADAMTS14 | Q8WXS8 | 296 |
| KRT73 | VWC2 | Q2TAL6 | 294 |
| KRT73 | A8MUN0 | A8MUN0 | 287 |
| KRT73 | CALCOCO1 | Q9P1Z2 | 278 |
IntAct
21 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KRT73 | KRT15 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT15 | KRT73 | psi-mi:“MI:0915”(physical association) | 0.560 |
| Nup107 | POM121C | psi-mi:“MI:0914”(association) | 0.350 |
| Tmed10 | TARS3 | psi-mi:“MI:0914”(association) | 0.350 |
| Smc1a | PDS5B | psi-mi:“MI:0914”(association) | 0.350 |
| Ttll7 | TK2 | psi-mi:“MI:0914”(association) | 0.350 |
| CCNB2 | SCAF4 | psi-mi:“MI:0914”(association) | 0.350 |
| ILK | ELOC | psi-mi:“MI:0914”(association) | 0.350 |
| MKI67 | ARHGAP10 | psi-mi:“MI:0914”(association) | 0.350 |
| TPT1 | EIF3F | psi-mi:“MI:0914”(association) | 0.350 |
| LRRK2 | psi-mi:“MI:0914”(association) | 0.350 | |
| SQSTM1 | CHEK1 | psi-mi:“MI:0914”(association) | 0.350 |
| KRT73 | EPPK1 | psi-mi:“MI:0914”(association) | 0.350 |
| KRT73 | IPO13 | psi-mi:“MI:0914”(association) | 0.350 |
| ARMC9 | PRMT5 | psi-mi:“MI:0914”(association) | 0.350 |
| PSMD12 | psi-mi:“MI:0914”(association) | 0.350 | |
| FHIP2A | MED19 | psi-mi:“MI:2364”(proximity) | 0.270 |
| KRT73 | tdk | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (63): KRT73 (Two-hybrid), KRT73 (Affinity Capture-MS), KRT73 (Affinity Capture-MS), KRT73 (Affinity Capture-MS), KRT73 (Affinity Capture-MS), KRT73 (Affinity Capture-MS), KRT73 (Affinity Capture-MS), KRT73 (Affinity Capture-MS), KRT73 (Affinity Capture-MS), KRT73 (Affinity Capture-MS), KRT73 (Affinity Capture-MS), KRT73 (Two-hybrid), KRT73 (Two-hybrid), KRT73 (Two-hybrid), KRT16 (Two-hybrid)
ESM2 similar proteins: A1L317, A1L595, A5A6N2, A6BLY7, B1AQ75, E1AB55, O76013, P02533, P08730, P08779, P13646, P19012, Q0P5J4, Q0P5J6, Q0P5J7, Q148H5, Q148H6, Q148H8, Q2M2I5, Q3UV17, Q497I4, Q61414, Q61781, Q64291, Q6IFU7, Q6IFU8, Q6IFV1, Q6IFV3, Q6IFV4, Q6IFW6, Q6IFW8, Q6IFX0, Q6IFX1, Q6IFX2, Q6NXH9, Q6R649, Q6R650, Q7Z3Y7, Q7Z3Y8, Q7Z3Y9
Diamond homologs: A0A125S9M6, A0JND2, A4FUZ0, A5A6M8, A6NCN2, A7YWK3, O43790, P02542, P02545, P02547, P02548, P04104, P04260, P04261, P04262, P04263, P07196, P07744, P08551, P08928, P09010, P10999, P12035, P12036, P13647, P13648, P15241, P16884, P19013, P19246, P19527, P21619, P21910, P25691, P35908, P48671, P48672, P48678, P48679, P78385
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
111 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 104 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1075 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 12:52608450:CCG:C | acceptor_gain | 1.0000 |
| 12:52608451:CGC:C | acceptor_gain | 1.0000 |
| 12:52609245:A:AC | donor_gain | 1.0000 |
| 12:52609246:C:CC | donor_gain | 1.0000 |
| 12:52609246:CAA:C | donor_gain | 1.0000 |
| 12:52609278:CATC:C | acceptor_gain | 1.0000 |
| 12:52609280:TC:T | acceptor_gain | 1.0000 |
| 12:52609281:CC:C | acceptor_gain | 1.0000 |
| 12:52609282:C:CC | acceptor_gain | 1.0000 |
| 12:52611325:TGGAA:T | acceptor_gain | 1.0000 |
| 12:52611327:GAA:G | acceptor_gain | 1.0000 |
| 12:52611328:AA:A | acceptor_gain | 1.0000 |
| 12:52611330:C:CC | acceptor_gain | 1.0000 |
| 12:52613685:CACC:C | donor_loss | 1.0000 |
| 12:52613686:A:AC | donor_gain | 1.0000 |
| 12:52613687:C:CC | donor_gain | 1.0000 |
| 12:52613848:GTCTC:G | acceptor_gain | 1.0000 |
| 12:52613849:TCTCC:T | acceptor_gain | 1.0000 |
| 12:52613850:CTC:C | acceptor_gain | 1.0000 |
| 12:52613851:TC:T | acceptor_gain | 1.0000 |
| 12:52613851:TCCTG:T | acceptor_loss | 1.0000 |
| 12:52613852:CC:C | acceptor_gain | 1.0000 |
| 12:52613853:C:CC | acceptor_gain | 1.0000 |
| 12:52613853:C:T | acceptor_gain | 1.0000 |
| 12:52613853:CT:C | acceptor_loss | 1.0000 |
| 12:52613856:C:CT | acceptor_gain | 1.0000 |
| 12:52614577:AC:A | donor_gain | 1.0000 |
| 12:52614577:ACC:A | donor_gain | 1.0000 |
| 12:52614577:ACCC:A | donor_gain | 1.0000 |
| 12:52614578:CC:C | donor_gain | 1.0000 |
AlphaMissense
3532 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 12:52618096:G:C | F143L | 0.990 |
| 12:52618096:G:T | F143L | 0.990 |
| 12:52618098:A:G | F143L | 0.990 |
| 12:52610805:C:G | A381P | 0.987 |
| 12:52615282:C:A | K240N | 0.986 |
| 12:52615282:C:G | K240N | 0.986 |
| 12:52615294:A:C | F236L | 0.983 |
| 12:52615294:A:T | F236L | 0.983 |
| 12:52615296:A:G | F236L | 0.983 |
| 12:52615316:C:G | R229P | 0.983 |
| 12:52618097:A:G | F143S | 0.983 |
| 12:52610636:A:G | L437P | 0.981 |
| 12:52615308:C:G | A232P | 0.981 |
| 12:52610642:C:G | R435P | 0.978 |
| 12:52618097:A:C | F143C | 0.978 |
| 12:52610772:C:G | A392P | 0.977 |
| 12:52618105:G:C | N140K | 0.973 |
| 12:52618105:G:T | N140K | 0.973 |
| 12:52616361:T:G | Q156P | 0.972 |
| 12:52610817:C:G | A377P | 0.971 |
| 12:52613711:C:G | A321P | 0.970 |
| 12:52610646:A:C | Y434D | 0.969 |
| 12:52610666:A:G | L427P | 0.969 |
| 12:52616370:A:G | L153P | 0.969 |
| 12:52611256:A:G | L353P | 0.968 |
| 12:52618087:G:C | F146L | 0.968 |
| 12:52618087:G:T | F146L | 0.968 |
| 12:52618089:A:G | F146L | 0.968 |
| 12:52618094:G:T | A144D | 0.966 |
| 12:52618106:T:A | N140I | 0.966 |
dbSNP variants (sampled 300 via entrez): RS1000063353 (12:52624037 A>G), RS1000072587 (12:52620816 T>C), RS1000354026 (12:52632244 G>A,C), RS1000472907 (12:52622857 G>A,C), RS1000742683 (12:52631471 G>A), RS1000875914 (12:52610198 C>T), RS1000891100 (12:52619092 A>C,G), RS1001067997 (12:52611998 G>A,T), RS1001167818 (12:52622337 T>A), RS1001239711 (12:52622583 C>T), RS1001325963 (12:52607270 C>T), RS1001375308 (12:52629097 G>A,C), RS1001392892 (12:52615964 G>T), RS1001804985 (12:52629411 C>A,T), RS1001807279 (12:52612997 A>C)
Disease associations
OMIM: gene MIM:608247 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
13 total (human), top 13 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | decreases methylation | 1 |
| terbufos | increases methylation | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Atrazine | increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cadmium | decreases expression | 1 |
| Dinitrochlorobenzene | affects binding | 1 |
| Fonofos | increases methylation | 1 |
| Parathion | increases methylation | 1 |
| Dihydrotestosterone | increases expression | 1 |
| Tobacco Smoke Pollution | affects expression | 1 |
| Lactic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.